0001213900-23-099335.txt : 20231228
0001213900-23-099335.hdr.sgml : 20231228
20231228184249
ACCESSION NUMBER: 0001213900-23-099335
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231228
FILED AS OF DATE: 20231228
DATE AS OF CHANGE: 20231228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Feldmann Marc
CENTRAL INDEX KEY: 0001832327
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 231523741
MAIL ADDRESS:
STREET 1: 5 DURHAM TERRACE
CITY: LONDON
STATE: X0
ZIP: W25PB
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 3000 EL CAMINO REAL
STREET 2: BLDG 4, STE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
X0508
4
2023-12-28
0
0001690080
180 Life Sciences Corp.
ATNF
0001832327
Feldmann Marc
3000 EL CAMINO REAL, BLDG. 4,
SUITE 200
PALO ALTO
CA
94306
1
0
0
0
0
Common Stock
2023-12-28
4
A
0
135377
0.0
A
250874
D
Granted to the Reporting Person pursuant to the Issuer's equity compensation plans in consideration for services rendered. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
/s/ Sir Marc Feldmann, Ph.D.
2023-12-28